InMed Pharmaceuticals Inc
Research InMed Pharmaceuticals Inc (INM) on Bullrun: market cap USD 7.26M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINM
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 7.26M
- Financial periodFY2026
- RevenueUSD 0
- Revenue growth-100.0%
- Net income-USD 12.56M
- Free cash flow-USD 8.64M
Valuation Snapshot
latest market cap is USD 7.26M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 0 | -USD 12.56M | -USD 8.64M | n/a | -3.12 | USD 2.19M | USD 0 | USD 1.08M |
| FY2025 | USD 4.94M | -USD 8.16M | -USD 7.77M | 34.5% | -8.36 | USD 10.74M | USD 741.26K | USD 13.43M |
| FY2024 | USD 4.60M | -USD 7.68M | -USD 7.00M | 23.9% | -20.14 | USD 6.57M | USD 962.66K | USD 9.21M |
| FY2023 | USD 4.14M | -USD 7.95M | -USD 7.44M | 33.9% | -3.25 | USD 8.91M | USD 391.71K | USD 12.09M |
| FY2022 | USD 1.37M | -USD 18.60M | -USD 15.62M | 39.8% | -33.17 | USD 6.18M | USD 793.77K | USD 9.08M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 7.26M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.97M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.43M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.75M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.21M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 18.54M | n/a | n/a | n/a |
About InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is InMed Pharmaceuticals Inc's market cap?
InMed Pharmaceuticals Inc's market capitalization is USD 7.26M.
What does InMed Pharmaceuticals Inc do?
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.